Arcus biosciences announces third quarter results

Arcus biosciences announces third quarter 2019 financial results and recent corporate updates.qtrly loss per share $0.51.cash, cash equivalents and investments were $197.0 million,as of september 30, 2019, compared to $224.4 million at june 30, 2019.q3 earnings per share view $-0.49 -- refinitiv ibes data.

RCUS Ratings Summary

RCUS Quant Ranking